Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,237,000 | N/A | 7,785,000 | 5,740,000 | 5,086,000 |
| Receivables | 8,234,000 | N/A | 8,547,000 | 8,606,000 | 8,464,000 |
| Inventories | 6,583,000 | N/A | 6,773,000 | 6,674,000 | 6,630,000 |
| Other current assets | 2,712,000 | 0 | 2,778,000 | 2,702,000 | 2,813,000 |
| TOTAL | $25,766,000 | $N/A | $25,883,000 | $23,722,000 | $22,993,000 |
| Non-Current Assets | |||||
| PPE Net | 15,772,000 | N/A | 16,199,000 | 16,067,000 | 16,248,000 |
| Investments And Advances | 27,722,000 | 0 | 0 | 0 | 0 |
| Intangibles | 62,726,000 | 0 | 64,202,000 | 64,743,000 | 65,856,000 |
| Other Non-Current Assets | 0 | 0 | 27,723,000 | 26,904,000 | 27,351,000 |
| TOTAL | $106,220,000 | $N/A | $108,124,000 | $107,714,000 | $109,455,000 |
| Total Assets | $131,986,000 | $N/A | $134,007,000 | $131,436,000 | $132,448,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,324,000 | N/A | 8,307,000 | 10,092,000 | 11,629,000 |
| Accounts payable and accrued liabilities | 4,566,000 | 0 | 4,662,000 | 4,920,000 | 4,704,000 |
| Other current liabilities | 13,440,000 | N/A | 11,635,000 | 11,259,000 | 11,484,000 |
| TOTAL | $26,330,000 | $N/A | $24,604,000 | $26,271,000 | $27,817,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,933,000 | N/A | 18,259,000 | 16,276,000 | 16,465,000 |
| Other Non-Current Liabilities | 15,078,000 | -7,000 | 16,073,000 | 16,355,000 | 16,277,000 |
| TOTAL | $38,010,000 | $N/A | $34,337,000 | $32,633,000 | $32,742,000 |
| Total Liabilities | $64,340,000 | $N/A | $58,941,000 | $58,904,000 | $60,559,000 |
| Shareholders' Equity | |||||
| Other shareholders' equity | 67,646,000 | 0 | 75,066,000 | 72,532,000 | 71,889,000 |
| TOTAL | $67,646,000 | $N/A | $75,066,000 | $72,532,000 | $71,889,000 |
| Total Liabilities And Equity | $131,986,000 | $0 | $134,007,000 | $131,436,000 | $132,448,000 |